BIOMAT Database Logo BIOMAT Database Logo

Clinical use of apolipoprotein quantitation. 1995

A M Johnson, and W Y Craig, and T B Ledue

UI MeSH Term Description Entries
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D016632 Apolipoprotein A-I The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. Apo A-I,Apo A-1,Apo A-I Isoproteins,Apo A1,Apo AI,ApoA-1,ApoA-I,Apolipoprotein A-1,Apolipoprotein A-I Isoprotein-2,Apolipoprotein A-I Isoprotein-4,Apolipoprotein A-I Isoproteins,Apolipoprotein A1,Apolipoprotein AI,Apolipoprotein AI Propeptide,Pro-Apo A-I,Pro-Apolipoprotein A-I,Proapolipoprotein AI,Apo A I Isoproteins,Apolipoprotein A 1,Apolipoprotein A I,Apolipoprotein A I Isoprotein 2,Apolipoprotein A I Isoprotein 4,Apolipoprotein A I Isoproteins,Pro Apo A I,Pro Apolipoprotein A I

Related Publications

A M Johnson, and W Y Craig, and T B Ledue
Clinical use of apolipoprotein quantitation.
January 1995, Annals of internal medicine,
A M Johnson, and W Y Craig, and T B Ledue
Clinical use of apolipoprotein quantitation.
January 1995, Annals of internal medicine,
A M Johnson, and W Y Craig, and T B Ledue
Quantitation of apolipoprotein E.
January 1996, Methods in enzymology,
A M Johnson, and W Y Craig, and T B Ledue
Quantitation of plasma apolipoprotein J.
January 1996, Methods in enzymology,
A M Johnson, and W Y Craig, and T B Ledue
Standardization procedures of immunochemical apolipoprotein quantitation.
January 1982, La Ricerca in clinica e in laboratorio,
A M Johnson, and W Y Craig, and T B Ledue
Quantitation of apolipoprotein B by chemical methods.
January 1996, Methods in enzymology,
A M Johnson, and W Y Craig, and T B Ledue
Chromatographic methods for quantitation of apolipoprotein A-I.
January 1996, Methods in enzymology,
A M Johnson, and W Y Craig, and T B Ledue
[Quantitation of human apolipoprotein B100 by immunoturbidimetric assay].
March 1997, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
A M Johnson, and W Y Craig, and T B Ledue
Quantitation of endogenous liver apolipoprotein B mRNA editing.
July 1990, Biochemical and biophysical research communications,
A M Johnson, and W Y Craig, and T B Ledue
Immunonephelometric quantitation of apolipoprotein E in human serum.
April 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
Copied contents to your clipboard!